Stocks · US
EW
XNYS
Edwards Lifesciences Corp
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E50.03x
P/B4.74x
P/S7.72x
EPS$1.74
ROE9.46%
ROA7.25%
Dividend yield0.00%
EV/EBITDA24.22x
Debt/Equity0.06
Free cash flow$1.4B
Returns and 52-week range
1W-1.82%
1M-3.80%
3M-7.65%
6M+6.98%
1Y+12.21%
YTD+1.35%
52W high$96.29
52W low$72.30
From 52W high-10.19%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Cardinal Health, Inc. | $54.0B | 31.49 | — | -5.56% |
| Becton, Dickinson and Co. | $49.2B | 52.30 | 2.02 | -2.40% |
| Cencora, Inc. | $60.1B | 22.90 | 19.70 | -4.41% |
| 휴마나 | $48.5B | 37.94 | 2.53 | +0.68% |
| Natera, Inc. Common Stock | $61.4B | — | 33.68 | +22.08% |
| Agilent Technologies Inc. | $48.3B | 33.54 | 6.56 | +12.24% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.